Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
A. Akram, J. Chalmers, A. Singanayagam, P. Mandal, G. Choudhury, A. Hill (United Kingdom). Failure to reach clinical stability in community acquired pneumonia. Eur Respir J 2010; 36: Suppl. 54, 4943

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006 Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Clinical presentation and evolution of community acquired pneumonia in older patients Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia Source: Eur Respir J 2001; 18: 362-368 Year: 2001 The clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia of the 3rd group Source: Eur Respir J 2007; 30: Suppl. 51, 548s Year: 2007 Severe community acquired pneumonia: clinical and aetiological evaluation Source: Eur Respir J 2007; 30: Suppl. 51, 673s Year: 2007 Fusing ICU clinical care and clinical research in severe community acquired pneumonia Source: International Congress 2016 – PG16 Infection control in epidemics: strengthening the evidence base for healthcare workers and the public Year: 2016 Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005 Management of community acquired pneumonia Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Management of community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Early outcomes in CAP: clinical stability, clinical failure and nonresolving pneumonia Source: Eur Respir Monogr 2014; 63: 205-218 Year: 2014 Factors related to obtain an etiological diagnosis in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Defining stability in pneumonia and the non-responding pneumonia Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 Management of community acquired pneumonia audit Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 The influence of CRB-65 and some clinical and epidemiological factors over approach to community acquired pneumonia Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas! Year: 2009 Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Quality-indicators and prognostics in CAP in three populations Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Predicting bacteraemia or rapid identification of the causative pathogen in community acquired pneumonia: where should the priority lie? Source: Eur Respir J 2016; 48: 619-622 Year: 2016